bm9b00887_si_001.pdf (1.08 MB)
Download fileAmino-Modified Polymer Nanoparticles as Adjuvants to Activate the Complement System and to Improve Vaccine Efficacy in Vivo
journal contribution
posted on 2019-08-28, 16:39 authored by Yong Pan, Yanxin Qi, Nannan Shao, Abegail C. Tadle, Yubin HuangSubunit
vaccines are safer but often poorly immunogenic in comparison
to traditional vaccines, and thus, adjuvants and delivery vehicles
are needed to enhance the immune response. The complement system is
a part of the innate immune system, which plays an important role
in innate and adaptive immunity. Therefore, the activation of the
complement system could be utilized as a potential strategy for vaccine
applications. Herein, cysteamine hydrochloride was grafted onto a
methoxy poly(ethylene glycol)-block-poly (allyl glycidyl
ether)-block-poly(ε-caprolactone) copolymer
to synthesize a triblock polymer mPEG5k-PAGE15(NH2)-PCL5k(TPCAH) with amino groups on the side chain. The
positive charge of the amino groups could bind with the negatively
charged protein (like ovalbumin (OVA)) to form a stable complex by
electrostatic interaction. The triblock copolymer TPCAH we designed
can easily self-assemble into polymer nanomicelles, and the size of
the nanoparticles is similar to that of the pathogens, which was beneficial
to the uptake by lymphocytes. Furthermore, the amino groups modified
on the side chain can not only integrate with proteins but also activate
the complement system, thereby enhancing the immune response of subunit
vaccines. The results showed that the complex TPCAH@OVA could efficiently
promote powerful anti-OVA-specific antibody production, enhance CD4+ T- and CD8+ T-cell activation, improve the lymphocyte
proliferation efficiency, and increase the secretion of different
cytokines. In addition, the abundant amino groups on the surface of
TPCAH@OVA could effectively activate the complement system to further
enhance adaptive immunity. Overall, these results indicated that the
triblock copolymer TPCAH as an adjuvant and carrier can effectively
improve the ability of innate and adaptive immune responses to resist
pathogens, making it a potential candidate for vaccine applications.